Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)
Close on Nov 17, 2026Market cap $41.44BP/E –Yield –
Natera operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Natera's operating cash flow for the twelve months ending Jun 30, 2026 was $228.24M, up 22.2% year over year. For fiscal 2025 it was $215.30M, up 58.7% from the year before. The highest annual figure on record is $215.30M in fiscal 2025.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $215.30M | +58.7% |
| FY2024 | Dec 31, 2024 | $135.66M | – |
| FY2023 | Dec 31, 2023 | -$246.96M | – |
| FY2022 | Dec 31, 2022 | -$431.50M | – |
| FY2021 | Dec 31, 2021 | -$335.24M | – |
| FY2020 | Dec 31, 2020 | -$182.51M | – |
| FY2019 | Dec 31, 2019 | -$63.44M | – |
| FY2018 | Dec 31, 2018 | -$70.58M | – |
| FY2017 | Dec 31, 2017 | -$97.83M | – |
| FY2016 | Dec 31, 2016 | -$74.05M | – |
| FY2015 | Dec 31, 2015 | -$37.83M | -460.6% |
| FY2014 | Dec 31, 2014 | $10.49M | – |
| FY2013 | Dec 31, 2013 | -$24.13M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $54.79M | +45.8% |
| Q1 FY2026 | Mar 31, 2026 | $40.17M | -9.6% |
| Q4 FY2025 | Dec 31, 2025 | $73.89M | +39.7% |
| Q3 FY2025 | Sep 30, 2025 | $59.39M | +14.7% |
| Q2 FY2025 | Jun 30, 2025 | $37.57M | +841.7% |
| Q1 FY2025 | Mar 31, 2025 | $44.45M | +64.6% |
| Q4 FY2024 | Dec 31, 2024 | $52.89M | – |
| Q3 FY2024 | Sep 30, 2024 | $51.79M | – |
| Q2 FY2024 | Jun 30, 2024 | $3.99M | – |
| Q1 FY2024 | Mar 31, 2024 | $27.00M | – |
| Q4 FY2023 | Dec 31, 2023 | -$57.61M | – |
| Q3 FY2023 | Sep 30, 2023 | -$29.70M | – |
| Q2 FY2023 | Jun 30, 2023 | -$78.54M | – |
| Q1 FY2023 | Mar 31, 2023 | -$81.11M | – |
| Q4 FY2022 | Dec 31, 2022 | -$81.13M | – |
| Q3 FY2022 | Sep 30, 2022 | -$102.25M | – |
| Q2 FY2022 | Jun 30, 2022 | -$110.85M | – |
| Q1 FY2022 | Mar 31, 2022 | -$137.28M | – |
| Q4 FY2021 | Dec 31, 2021 | -$98.74M | – |
| Q3 FY2021 | Sep 30, 2021 | -$91.06M | – |
| Q2 FY2021 | Jun 30, 2021 | -$70.56M | – |
| Q1 FY2021 | Mar 31, 2021 | -$74.88M | – |
| Q4 FY2020 | Dec 31, 2020 | -$73.30M | – |
| Q3 FY2020 | Sep 30, 2020 | -$33.13M | – |
| Q2 FY2020 | Jun 30, 2020 | -$40.98M | – |
| Q1 FY2020 | Mar 31, 2020 | -$35.10M | – |
| Q4 FY2019 | Dec 31, 2019 | -$15.05M | – |
| Q3 FY2019 | Sep 30, 2019 | -$48.39M | – |
| Q2 FY2019 | Jun 30, 2019 | -$35.75M | – |
| Q1 FY2019 | Mar 31, 2019 | -$31.82M | -3142.0% |
| Q4 FY2018 | Dec 31, 2018 | -$12.81M | – |
| Q3 FY2018 | Sep 30, 2018 | -$23.27M | – |
| Q2 FY2018 | Jun 30, 2018 | -$35.54M | – |
| Q1 FY2018 | Mar 31, 2018 | $1.05M | – |
| Q4 FY2017 | Dec 31, 2017 | -$28.13M | – |
| Q3 FY2017 | Sep 30, 2017 | -$31.30M | – |
| Q2 FY2017 | Jun 30, 2017 | -$13.77M | – |
| Q1 FY2017 | Mar 31, 2017 | -$24.62M | – |
| Q4 FY2016 | Dec 31, 2016 | -$29.65M | – |
| Q3 FY2016 | Sep 30, 2016 | -$24.22M | – |
See a number that looks wrong?